AbbVie and Simcere Zaiming announced a licensing option agreement to develop SIM0500, a trispecific antibody targeting multiple myeloma. Currently in Phase I trials, SIM0500 induces strong...
Owkin, in partnership with Servier, is organizing a global AI hackathon to accelerate glioblastoma research. Over 100 experts will analyze patient data, including multi-omics and spatial...
Benchling’s 2024 Biopharma Technology Landscape reveals that 67% of large biopharma companies use AI, compared to 23% of small firms. AI accelerates drug discovery, yet challenges...
Flomics Biotech’s liquid biopsy detects five cancers—colon, lung, prostate, pancreas, and breast—with 92% accuracy. Using RNA biomarkers, AI, and next-generation sequencing, it identifies early-stage cancer with...
A study by CIBER, IIS-FJD, and IIB Sant Pau highlights annexin A8 (AnxA8) as a key player in atherosclerosis progression. AnxA8 upregulation in human and murine...
Spain funded 17 new orphan drugs in 2024, totaling 85 within the NHS, covering 58% of EU-approved orphan medicines. Three advanced therapies were funded, the first...
Researchers led by Fernando Moreno-Herrero discovered a novel bacterial gene regulation mechanism involving KorA and KorB proteins. KorB slides along DNA, regulated by CTP binding and...
Technological advances in genomics, AI, and immunology are transforming breast cancer research, enabling personalized treatments and improved understanding of tumor biology. Key focuses include hereditary genetics,...
The Clara Campal Comprehensive Oncology Centre (HM Ciocc) leads cancer research in Madrid's private sector, with 144 trials recruiting and 374 active studies in 2024. Focused...
AseBio and Aelmhu praised the first Joint Committee meeting on Spain’s 2024-2028 Pharmaceutical Industry Strategy, emphasizing collaboration between ministries and industry. AseBio supports fostering biotechnology growth,...